Therapeutic Advances in Endocrinology and Metabolism

Papers
(The H4-Index of Therapeutic Advances in Endocrinology and Metabolism is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Effect of sodium-glucose cotransporter-2 inhibitors on patients with essential hypertension and pre-hypertension: a meta-analysis134
In-person and virtual multidisciplinary intensive lifestyle interventions are equally effective in patients with type 2 diabetes and obesity121
Treatment of osteoporosis in the solid organ transplant recipient: an organ-based approach63
The global burden of thyroid cancer in high-income Asia-Pacific: a systematic analysis of the Global Burden of Disease study40
Role of epicardial adipose tissue in diabetic cardiomyopathy through the lens of cardiovascular magnetic resonance imaging – a narrative review37
Controversies in the management of active Charcot neuroarthropathy31
Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse adults31
Insulin therapy among diabetic patients in rural communities of Sub-Saharan Africa: a perspective review27
Glycaemic outcomes in people living with diabetes under 65 and over 65 years old using an intermittently scanned continuous glucose monitoring system22
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease22
Differences in adherence to using removable cast walker treatment during daytime and nighttime weight-bearing activities in people with diabetes-related foot ulcers21
Effectiveness of open-source Android artificial pancreas systems for glucose management in patients with type 1 diabetes: a real-world study21
Novel therapeutic targets for metabolism-related diseases: proteomic Mendelian randomization and colocalization analyses21
Update on genetics and epigenetics in metabolic associated fatty liver disease21
Chronic kidney disease combined with metabolic syndrome is a non-negligible risk factor20
Pheochromocytoma: a changing perspective and current concepts19
Is there a causal relationship between hypothyroidism and hyponatremia?18
Prevalence and associated factors of hyperuricemia among Chinese patients with diabetes: a cross-sectional study17
Design and rationale for the SIB trial: a randomized parallel comparison of semaglutide versus placebo on intestinal barrier function in type 2 diabetes mellitus17
Using digital tools to improve diabetes care in India with continuous glucose monitoring17
Diagnostic performance of morning basal serum cortisol for assessing adrenal reserve: a single-center experience from the United Arab Emirates17
0.22700381278992